Iron levels in the brain associated with accelerated cognitive decline

Researchers in Australia have found a link between iron levels in the brain and accelerated cognitive decline in patients with Alzheimer’s disease (AD).

They measured iron levels in the post-mortem brains of 645 patients with a wide spectrum of neurocognitive impairment who participated in the US-based Memory and Aging Project.

Iron levels were assessed in the inferior temporal, mid frontal, anterior cingulate, and cerebellar regions. Cognitive function was assessed annually as part of the study.

“This is the largest post-mortem study of brain iron in AD,” noted Dr Ashley Bush of the University of Melbourne, Australia. “We examined iron in multiple brain regions in a large cohort across the clinicopathological staging of the disease, with extensive cognitive data collected in the decade prior to death.”

Want to read more?

Log in or sign up to access all Neurodiem content.

Already have an account? Log In

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.